Business Wire

Murata Announces Production of "CELLNETTA" – the World's First Metal Cell Fractionation Filter

Share

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) announced today that has successfully commercialized and mass produced "CELLNETTA," the world’s first*1 metal cell fractionation filter designed for the rapid and precise selection and recovery of target cells from cell suspensions*2 used in regenerative medicine and cell pharmaceutical research and development. Target applications include fractionation (selection and recovery), concentration, and filtration in research and development for regenerative medicine technologies or cellular pharmaceuticals, as well as biotechnology across agriculture, forestry, food, and energy industries. The product will be showcased at the 24th Annual Meeting of the Japanese Society for Regenerative Medicine happening March 20-22, 2025 at Pacifico Yokohama North.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250312846176/en/

[Murata Manufacturing Co., Ltd.] "CELLNETTA" –the metal cell fractionation filter

*1 According to our research (as of March 16, 2025)

In recent years, regenerative medicine and cell therapy have gained worldwide recognition for their potential to treat previously incurable diseases by restoring lost cells or bodily functions. However, these advancements face significant challenges, including the substantial costs and time required for research and development. To accelerate the delivery of effective medical technologies and pharmaceuticals to clinical settings, innovative methods that can streamline the R&D process are urgently needed.

In developing this product, the Company focused on the process of selecting and recovering target cells from cell suspensions – a critical step in research related to regenerative medicine and cell therapy. The CELLNETTA solution features microscale pores arranged in a mesh structure on a thin metallic film, created using advanced thin-film microfabrication technology honed over years of electronic component manufacturing. By precisely controlling the pore sizes on the thin metal film, which minimizes cell adhesion, this filter enables efficient selection and recovery of target cells without leaving residues.

Historically, selecting and recovering target cells required skilled personnel and equipment, such as centrifuges*3, or the use of membrane filters made from fibers or resins. CELLNETTA simplifies this process by eliminating the need for specialized skills and bulky devices, enabling quicker selection and recovery of target cells compared to fiber- or resin-based filters. This innovative method not only streamlines tasks that were once considered challenging with conventional techniques but also offers high-precision fractionation. Key features include:

  • Rapid Separation of Target Cells
    The filter's large open area enables efficient separation of target cells from liquid media without the need for pumps; simply pouring the cell suspension is sufficient.

Case Study 1: Time taken to pass 50 ml of Phosphate-Buffered Saline (PBS) through a membrane filter with a pore size of 5 µm compared to CELLNETTA.
Membrane Filter: Approx. 5 minutes
CELLNETTA: Approx. 20 seconds
Note: Since the membrane filter relies on applied pressure for fluid passage, it is not feasible to measure the flow times under identical conditions.

Case Study 2: Time required to process a 10 ml cell suspension of HL-60 cells at a concentration of 1×105 cells/ml using a centrifuge versus CELLNETTA.
Centrifuge: Approx. 5 to 15 minutes
CELLNETTA: Approx. 50 seconds

  • High Precision in Cell Fractionation
    Featuring uniform micrometer-scale pores, the filter allows for precise fractionation tailored to target cell sizes by selecting the appropriate mesh size.
  • Considerations for Biocompatibility and Hygiene
    The filter is made from biocompatible metal materials designed to minimize any impact on processed cells. Each product is individually packaged and sterilized using gamma-ray irradiation.
  • Wide Range of Product Options
    The filter is offered in six mesh sizes (5µm, 10µm, 15µm, 20µm, 100µm, 200µm), making it adaptable for a wide range of target cells and suitable for various applications.

Murata is dedicated to fostering innovation across various sectors, including healthcare, while providing solutions that address pressing social challenges. For more details, please visit here. For inquiries regarding CELLNETTA, click here.

*CELLNETTA is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease or any other medical condition. CELLNETTA is not designed, manufactured, or marketed as a medical device as defined by applicable laws and regulations.
*2 A cell suspension refers to a fluid that has cells or microorganisms suspended (floating or dispersed) in a liquid medium during culture. In research and technology development related to regenerative medicine, biotechnology, and cell biology, cell suspensions are managed throughout various processes such as tissue collection, cell purification, culture, passaging/splitting, administration, pre-surgical preparation, concentration, and quality inspection while selecting and recovering target cells.
*3 Centrifugation: A method that utilizes differences in density to separate and recover target cells through centrifugal force.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250312846176/en/

Contacts

For more information, please contact:
Murata Manufacturing Co., Ltd.
Tatsuki Ichioka
prsec_mmc@murata.com
Corporate Communications Department

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Adara Ventures Announces First Close of €100M AV4 Fund, Targeting Cybersecurity, AI & Digital Infrastructure17.3.2025 12:03:00 EET | Press release

Adara Ventures, the European venture capital firm specialising in early-stage deep tech investments, today announced the first close of its fourth flagship fund, AV4, targeting €100 million in capital commitments. This new fund reinforces Adara’s commitment to delivering strong returns in strategic sectors, including cybersecurity, applied AI, digital infrastructure, hardware components, digital health, and space. “We are immensely proud to announce the successful first close of AV4,” said Nico Goulet, Founding Partner of Adara Ventures. “Over the past nine months, we have secured in excess of €140 million in commitments across our fourth-generation funds. Alongside AV4, this includes Adara Ventures Energy (AVE), our first Pan-European fund dedicated to energy transition technologies. In one of the most challenging fundraising environments of the past 20 years, our strong DPI record, disciplined investment strategy, and focused fund model make AV4 a compelling opportunity for our limit

Astronauts’ Health During Space Missions: Nichi BRITE and Neu REFIX Beta Glucans Could Benefit by Neutrophil-to-Lymphocyte Ratio, IL-6 Control, the Immune Biomarkers of Aging and Longevity17.3.2025 11:22:00 EET | Press release

Neutrophil to Lymphocyte ratio (NLR) is a critical biomarker of health of astronauts during space mission, and that of aging related illnesses, inflammaging, longevity and cancer prognosis. Oral consumption of AFO-202 strain of Aureobasidium pullulans produced Nichi BRITE and N-163 strain produced Neu REFIX together in pre-clinical and clinical studies having safely and beneficially modified NLR, are considered holding potential to help maintain astronauts health during space flight and also to bridge the gap between health span and life span by ‘Me-Byo’ phenomenon as published in Frontiers in Immunology while Neu REFIX standalone yielding enhanced dystrophin, an additional benefit that might help prevent muscle loss during space missions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250316966059/en/ Astronauts during space missions, deep-sea researchers, high-altitude climbers, and workers exposed to radiation hazards, ar

Cineca to House Italy’s Most Powerful Quantum Computer IQM Radiance 5417.3.2025 11:04:00 EET | Press release

Italian supercomputing centre Cineca today announced an agreement with IQM Quantum Computers, a global leader in superconducting quantum computers, to deliver the most powerful quantum computer in Italy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250317715500/en/ IQM Radiance 54-qubit superconducting quantum computer IQM Radiance quantum computer, powered by IQM’s 54-qubit quantum processing unit (QPU), will be installed in the fourth quarter of 2025. The quantum computer will be integrated into Leonardo, which is one of the world’s fastest supercomputers. This will mark a major technology and innovation milestone for Italy and the larger quantum ecosystem. The installation will also be the first on-premises quantum computer at Cineca, which further consolidates the institution’s position as a centre of excellence for scientific computing internationally and strengthens Italy’s position in quantum computing. IQM intends

Alipay+ Empowers New Growth Opportunities for Malaysian SMEs, Contributing More Than 80% of Inbound QR Payments via DuitNow17.3.2025 10:00:00 EET | Press release

In their first full year of partnership in 2024, Payments Network Malaysia Sdn Bhd (PayNet) and Ant International, a leading global digital payment, digitisation and financial technology provider, brought new economic opportunities to Malaysian SMEs, with Alipay+ making up more than 80 percent of cross-border inbound QR payments via DuitNow. In the peak travel season in December 2024, the partnership enabled 6 times growth in revenue for Malaysian merchants, compared to the same period in 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250317987292/en/ Malaysian SMEs can connect with global customers via DuitNow QR and Alipay+ In October 2023, Alipay+, a unified wallet gateway with cross-border payment and digitisation services under Ant International, went live on DuitNow QR, enabling Malaysian SMEs to accept QR payments from international travellers. Today, the number of Alipay+ payment partners that can make payment

NTT DATA and CrowdStrike Expand Partnership to Strengthen AI-Powered Cyber Resilience17.3.2025 10:00:00 EET | Press release

NTT DATA, a global digital business and IT services leader, and CrowdStrike, a global cybersecurity leader, today announced an expanded partnership to power NTT DATA's managed cybersecurity services with the AI-native CrowdStrike Falcon® cybersecurity platform. Cyberattacks are growing faster, stealthier and more sophisticated, while the cybersecurity skills gap leaves organizations vulnerable. To protect against modern threats, clients need AI-native platform technology and the benefits of a managed security solution to reduce complexity and serve as a force multiplier for security and IT teams. By combining NTT DATA’s world-class managed services with the power of the Falcon platform, clients gain the protection they need to stop breaches. Key capabilities of the partnership include: Integrated Managed Security Services: The integration of the Falcon platform with NTT DATA’s managed services provides organizations with advanced threat detection and response across their digital envir

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye